Followers | 376 |
Posts | 17085 |
Boards Moderated | 4 |
Alias Born | 03/07/2014 |
![](https://investorshub.advfn.com/uicon/458287.png?cb=1657037051)
Wednesday, December 30, 2020 8:54:20 AM
The "company" is a few dudes in a rented dump of a house in AZ.
NO facility, no employees, no medical research labs, nothing - it's classic OTC VAPOR-WARE Inc based on nothing.
ALMOST $ZERO cash-on-hand at any given time per their own SEC filings.
"Animal model" BS PR ABOUT NOTHING = AT LEAST $500 million needed if not $1 ba BILLION and TEN YEARS TO AN FDA APPROVED PRODUCT -
CELZ has never run or conducted a SINGLE FDA CLINICAL TRIAL- EVER !!!
Just funding a FDA clinical phase I trial is $100 ma MILLION EASY and this "company" HAD (past tense) $38K cash on hand LMFAO !!!!
They OWE over $1 MILLION in gutter grade toxic death spiral notes - aka bottomless 100% dilutive toxic debt of the worst kind !
CELZ AFTER a Jan 2020 MASSIVE 1-for-150 REVERSE SPLIT went right back down to .00X per share LOSING A LITERAL 99.99% OF COMMON SHARE "VALUE" LMFAO !!!
BUYERS BEWARE: CELZ = A SHARE PRINTING DILUTION MILL SCAM MACHINE ON THE OTC !!!
RUN LIKE ESCAPING A NUCLEAR HOLOCAUST !!!
https://www.sec.gov/Archives/edgar/data/1187953/000110465920009235/tm206374-1_8k.htm
JAN 2020 = 11 SHORT MONTHS AGO = CELZ-a-CON DID A MASSIVE 1 for 150 REVERSE SPLIT and then went on to LOSE IT ALL BACK AND THEN SOME MORE :)
CELZ-a-CON = a OTC TRASH-n-SCAM SHARE PRINTING DILUTION MACHINE MACHINE !!!
QUOTE FROM SEC 8-K FILING :
"Item 3.03 Material Modification to Rights of Security Holders.
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
As previously reported, the Board of Directors and stockholders of Creative Medical Technology Holdings, Inc., a Nevada corporation (the “Company”), have approved a reverse stock split of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a ratio of 1-for-150 (the “Reverse Stock Split”).
The Reverse Stock Split will become effective pursuant a Certificate of Amendment (the “Certificate”) filed by the Company with the Secretary of State of the State of Nevada on January 28, 2020 pursuant to Nevada Revised Statutes (“NRS”) Sections 78.385 and 78.390. A copy of the Certificate has been filed as Exhibit 3.1 hereto and is incorporated herein by reference.
"
Posts contain only my amateur opinions, personal views and thoughts. I discuss stocks as a hobby only. Always do one's own due diligence before investing.
Recent CELZ News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 08:10:25 PM
- Creative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine Program • GlobeNewswire Inc. • 07/24/2024 01:00:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • GlobeNewswire Inc. • 07/10/2024 12:30:00 PM
- Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM